cstnprapp10.centerstone.lan

Centerstone Receives 2004 “Helping Move Lives Forward” Reintegration Award

$5,000 Eli Lilly Grant Supports Behavioral Healthcare Provider’s Outreach to People with Mental Illness



Nashville, Tenn.
— Centerstone, the largest behavioral healthcare provider in Tennessee, has been honored by Eli Lilly and Company with a $5,000 grant that will contribute to the work of ReConnect, a Centerstone program that helps those with mental illness take charge of their own recovery.

Centerstone received first prize in the social support category and will accept the award tonight at a ceremony in Indianapolis. Since 1997, the Helping Move Lives Forward Reintegration Awards program has recognized individuals, groups and initiatives that improve the lives of people with mental illness. An independent panel of mental health professionals and consumers determines the award recipients.

ReConnect, which is comprised of eight facilities formerly known as “drop-in centers,” provides peer support, socialization and educational services to adults who have suffered or are currently suffering from mental illness. ReConnect is located in nine cities across Middle Tennessee and serves 21 counties.

“Centerstone thanks and applauds Eli Lilly and Company for supporting our efforts to help people with mental illness help themselves,” said David Guth, CEO of Centerstone. “ReConnect offers shelter from the storm of mental illness, a shelter that is considerably reinforced by Eli Lilly’s contribution and recognition.”

ReConnect provides an accepting environment for adult peers with mental illness to work together to regain health, confidence, self-worth and self-respect. ReConnect participants take charge of their own lives by focusing on both recovery and social reintegration. Members plan the program’s activities and learn practical lessons about budgeting, accepting responsibility and working as a team.

“Lilly is very pleased to acknowledge the extraordinary efforts of all of the award recipients and their contributions in the area of recovery for people with severe mental illness,” said Dr. John Lechleiter, Executive Vice President of Pharmaceutical Operations, Eli Lilly and Company. “Lilly is committed to the recovery of people with mental illness, and we want to recognize the noble efforts of this year’s award winners who have helped many people with mental illness to reach their full potential and live happier and healthier lives.”

About the Reintegration Awards

The Reintegration Awards program underscores the powerful and collaborative roles of consumer involvement, treatment team support and access to effective medication in helping people move their lives forward. The awards honor individuals or groups who help and support people living with severe mental illness; the achievements of people living with severe mental illness who offer hope to others facing similar challenges; and local and national efforts to raise awareness for mental illness.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers — through medicines and information — for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com.